Selumetinib 17228-0635
Product NDC
17228-0635- Manufacturer
- Astrazeneca Ab
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- September 10, 2025
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Selumetinib | 5 mg/1 |
Packaging Options(1)
8000 CAPSULE in 1 DRUM (17228-0635-0)